0.09
-0.0059(-6.48%)
Currency In USD
Address
201 Haskins Way
South San Francisco, CA 94080
United States of America
Phone
(650) 407-2376
Website
Sector
Healthcare
Industry
Biotechnology
Employees
8
First IPO Date
November 30, 2021
| Name | Title | Pay | Year Born |
| Christopher Ehrlich | Chief Executive Officer & Chair | 1.08M | 1970 |
| Andrew Albert Kucharchuk | Chief Financial Officer | 252,000 | 1981 |
| Kristen Pierce | Chief Development Officer | 360,000 | 1970 |
| Lawrence Corey | Co-founder & Head of Scientific Advisory Board | 0 | 1947 |
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
